IL1B and Hypertension: Moreover, the level of IL-6, instead of IL-1β, decreased in NLRP3-/- mice, which means that NLRP3 is widely involved in diverse inflammatory responses, and anti-NLRP3 treatment would receive further benefits of relieving auto-inflammation in hypertension pathogenesis (87).